Use case

Discover the FormularyDecisions® Biosimilar Hub

The biosimilars market is growing rapidly, but navigating this evolving landscape can be complex for healthcare decision-makers (HCDMs). Cencora’s industry-recognized FormularyDecisions Biosimilar Hub streamlines the decision-making process by consolidating essential biosimilar information in one easy-to-use platform.
Doctor using a tablet
Doctor using a tablet
This innovative hub empowers HCDMs with tools to:
  • Stay updated on biosimilar approvals, launches, and pipeline developments.
  • Access clinical efficacy and safety data to support evidence-based decisions.
  • Explore therapeutic options with an intuitive indication tool.
  • Navigate state-specific substitution laws with ease.

Recognized for its excellence in pharmaceutical education, the Biosimilar Hub adopts a systematic, patient-first approach to simplify biosimilar research, improve patient outcomes, and reduce healthcare costs.

Explore how the FormularyDecisions Biosimilar Hub can help you make informed, trusted decisions for your organization and patients. Download the use case below:
Doctor using a tablet
* Available in English only.

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape

Webinar

Unlocking Access: Navigating Pharma’s Regulatory Crossroads

Report

Unlock the future of market access in 2026: Cencora’s essential guide to navigating a shifting healthcare landscape